A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated Triglycerides
Clinical trial NCT01262638 · COMPLETED
Trial details
- NCT number
- NCT01262638
- Sponsor
- Esperion Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2011-08-23
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.